Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Liabilities and Shareholders Equity: 2012-2025

Historic Liabilities and Shareholders Equity for Veracyte (VCYT) over the last 12 years, with Sep 2025 value amounting to $1.4 billion.

  • Veracyte's Liabilities and Shareholders Equity rose 7.28% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year increase of 10.43%. This contributed to the annual value of $1.3 billion for FY2024, which is 16.60% up from last year.
  • Per Veracyte's latest filing, its Liabilities and Shareholders Equity stood at $1.4 billion for Q3 2025, which was up 1.76% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Veracyte's Liabilities and Shareholders Equity ranged from a high of $1.4 billion in Q3 2025 and a low of $1.0 billion during Q1 2021.
  • Its 3-year average for Liabilities and Shareholders Equity is $1.2 billion, with a median of $1.2 billion in 2024.
  • Per our database at Business Quant, Veracyte's Liabilities and Shareholders Equity spiked by 300.19% in 2021 and then decreased by 5.09% in 2022.
  • Quarterly analysis of 5 years shows Veracyte's Liabilities and Shareholders Equity stood at $1.2 billion in 2021, then decreased by 2.64% to $1.2 billion in 2022, then declined by 3.59% to $1.1 billion in 2023, then increased by 16.60% to $1.3 billion in 2024, then climbed by 7.28% to $1.4 billion in 2025.
  • Its Liabilities and Shareholders Equity was $1.4 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.